Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 520
Selected: 0
NCT IDTitle
NCT06454448Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
NCT05678933AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT01660399Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy
NCT06867432Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma
NCT06241066The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
NCT05395429Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
NCT01635465Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer
NCT04137679Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT06375642A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
NCT06289062Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
NCT01788137A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients
NCT07263360Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
NCT01405079Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
NCT05273827Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
NCT07244874Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC
NCT06061146Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC
NCT05582109Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma
NCT04171986Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis
NCT05595590Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
NCT05679050Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
NCT07083375A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
NCT01745107Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT04443478Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT04843215A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT07321015A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance
NCT07330050WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
NCT01637350Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes
NCT06322563Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
NCT05908747Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer
NCT01634984The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT06954558A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
NCT06093438Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
NCT04936750A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal Cancer
NCT03731442Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT02024438Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer
NCT03478449The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer
NCT03874000Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
NCT07031700A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL
NCT05235932the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer
NCT06487663TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NCT01618474Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients
NCT04846634Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
NCT05077839Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC
NCT05651672Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
NCT05535647Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT04836728Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer
NCT05934864Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
NCT06375486Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma(uHCC).
NCT04108494A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy
NCT03950154Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer